9 / 33
Study 19: To assess the efficacy and safety of Olaparib as maintenance treatment in
HGSOC:
A randomised, double-blind, placebo-controlled Phase II maintenance study 265
patients in 82 investigational sites in 16 countries
Ledermann J. N Engl J Med 2012